Fed Rejects MetLife's (MET) Plans to Resume Buyback, Raise Dividend
Tweet
Share
E-mailGet Alerts MET Hot Sheet
Price: $80.96 -2.25%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 3%
Revenue Growth %: +9.9%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 3%
Revenue Growth %: +9.9%
Join SI Premium – FREE
Shares of MetLife (NYSE: MET) are ticking lower after hours Tuesday following news the Fed rejected the company's plan seeking approval to resume its stock repurchase program, as well as raise its quarterly dividend.
The Fed said these capital actions first need to be tested under a "revised scenario."
After closing at $32.83, the stock last traded at $32.40.
The Fed said these capital actions first need to be tested under a "revised scenario."
After closing at $32.83, the stock last traded at $32.40.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- W. R. Berkley declares special dividend, raises quarterly payout 11.1%
- Bitmine Immersion Technologies plans $300 million preferred stock offering
- McGrath Rentcorp (MGRC) Declares $0.495 Quarterly Dividend; 1.9% Yield
Create E-mail Alert Related Categories
Corporate News, Dividends, Stock BuybacksRelated Entities
Dividend, Stock BuybackSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
